Apply Now for AACR Cancer Research Awards

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

The American Association for Cancer Research (AACR) has announced the availability of its four annual research awards. The Gertrude Elion award, provided through an educational grant from Glaxo Wellcome Oncology, is open to nontenured cancer researchers in clinical, basic, or translational research in the United States and Canada.

The American Association for Cancer Research (AACR) has announcedthe availability of its four annual research awards. The GertrudeElion award, provided through an educational grant from GlaxoWellcome Oncology, is open to nontenured cancer researchers inclinical, basic, or translational research in the United Statesand Canada.

The two 1997 Research Fellowships in Clinical/Translational Research,sponsored by Amgen, Inc. and Bristol-Myers Squibb Oncology, andthe 1997 Research Fellowship in Basic Research will go to scientistswho have been postdoctoral or clinical fellows at an academicinstitution in the United States or Canada for at least, but notmore than, 5 years.

A completed application form and sponsorship by an AACR memberare required for each award. The application deadline is February14, 1997. For application forms, contact Jenny Anne Horst-Martzby phone: 215-440-9300; fax: 215-440-9313; or e-mail: aacr@aol.com.

Recent Videos
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Related Content